Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
Cleerly is a pioneering digital health organization that is revolutionizing how healthcare professionals manage heart disease. Our innovative clinical technologies are designed to enable clinicians to detect and accurately characterize atherosclerosis at an earlier stage, allowing for the development of customized and potentially life-saving treatment strategies for patients throughout their healthcare journey. Rather than relying on indirect indicators like risk factors or symptoms, we focus on measuring atherosclerosis directly, which is the accumulation of plaque in the arteries of the heart. By utilizing our AI-driven digital care pathways, we provide streamlined, rapid, and precise diagnostics and reporting that cater to the needs of all stakeholders, leading to enhanced clinical and financial results. Cleerly equips healthcare providers to transcend conventional assessments of heart disease by thoroughly analyzing, characterizing, and quantifying various plaque types. This advanced approach enables clinicians to better assess a patient's likelihood of experiencing a heart attack and to formulate effective treatment plans that aim to enhance overall heart health, ultimately fostering improved patient outcomes and quality of care.
Description
Oncoustics is pioneering the development and application of innovative, patented AI technologies aimed at providing low-cost, non-invasive surveillance, diagnostics, and treatment monitoring for diseases that currently face significant clinical challenges. The company has developed a range of specialized applications focused on various diseases and anatomical structures that are compatible with any point-of-care ultrasound device, allowing physicians, nurses, and technicians to operate them as essential tools in a primary care setting without requiring image analysis. By leveraging AI, Oncoustics transforms affordable point-of-care ultrasound machines into robust diagnostic instruments capable of facilitating quick and economical identification and monitoring of conditions affecting the liver, prostate, kidney, breast, and thyroid. The multidisciplinary team behind Oncoustics consists of professionals with expertise in AI, signal processing, radiology, hepatology, digital health, and ultrasound, ensuring a comprehensive approach to healthcare innovation. The emphasis on cost-effective point-of-care diagnostics and surveillance significantly enhances patient outcomes through timely detection and consistent monitoring, which are crucial for effective disease management and better overall health. As such, Oncoustics is not only addressing immediate healthcare needs but is also setting the stage for a transformation in how we approach disease management in the future.
API Access
Has API
API Access
Has API
Integrations
No details available.
Integrations
No details available.
Pricing Details
No price information available.
Free Trial
Free Version
Pricing Details
No price information available.
Free Trial
Free Version
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Vendor Details
Company Name
Cleerly
Country
United States
Website
cleerlyhealth.com
Vendor Details
Company Name
Oncoustics
Country
Canada
Website
oncoustics.com